Physicochemical characterization of papain entrapped in ionotropically cross-linked kappa-carrageenan gel beads for stability improvement using Doehlert shell design

Journal of Pharmaceutical Sciences

Volumn 95, Issue 9, 2006, Pages 1994-2013

  Sankalia, Mayur G ^a   Mashru, Rajshree C ^a   Sankalia, Jolly M ^a   Sutariya, Vijay B ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Composite index (CI); Doehlert shell design; DSC; FTIR; Ionotropic gelation; Mathematical models; Papain; Stability study; carrageenan

Indexed keywords

CARRAGEENAN; PAPAIN; POLYMER; POTASSIUM CHLORIDE;

ARTICLE; CALORIMETRY; DRUG STABILITY; DRUG STRUCTURE; ENZYME RELEASE; ENZYME STABILITY; GEL; INFRARED SPECTROSCOPY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROTEIN AGGREGATION; SCANNING ELECTRON MICROSCOPY; SHELF LIFE;

EID: 33748932172     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20665     Document Type: Article

References (50)

1. Schirmeister T, Otto H-H. 1997. Cysteine proteases and their inhibitors. Chem Rev 97:133-171.
2. Higaki JN, Evnin LB, Craik CS. 1989. Introduction of a cysteine protease active site into trypsin. Biochemistry 28:9256-9263.
3. Uhlig H. 1998. Description of enzymes. Industrial enzymes and their applications, 1st ed., New York, Singapore, Toronto: A Wiley-Intersciences Publication-John Wiley & Sons. Inc., pp 37-202.
4. Bickerstaff GF. 1997. Immobilization of enzymes and cells: Some practical considerations. In: Bickerstaff GF, editor. Immobilization of enzymes and cells, 1st ed., Totowa, New Jersey: Humana Press, pp 1-12.
5. Heinamaki J, Marvola M, Happonen I, Westemarck E. 1988. The fate of multiple unit entric coated formulations in the stomach of the dog. Int J Pharm 42:105-115.
6. Lin S-Y. 1993. Release kinetics of drug from different combined retios of micropellets. J Microencapsul 10:319-327.
7. Ritschel WA. 1991. Targeting in the gastrointestinal tract: New approaches. Methods Find Exp Clin Pharmacol 13:313-336.
8. Chen H, Langer R. 1997. Magnetically-responsive polymerized liposomes as potential oral delivery vehicles. Pharm Res 14:537-540.
9. Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL. 1997. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 14:1568-1573.
10. Picker KM. 1999. Matrix tablets of carrageenans. II. Release behavior and effect of added cations. Drug Dev Ind Pharm 25:339-346.
11. Suzuki S, Lim JK. 1994. Microencapsulation with carrageenan-locust bean gum in a multiphase emulsification technique for sustained drug release. J Microencapsul 11:197-203.
12. Sipahigil O, Dortunc B. 2001. Preparation and in vitro evaluation of verapamil HCl and ibuprofen containing carrageenan beads. Int J Pharm 228: 119-128.
13. Garcia AM, Ghaly ES. 1996. Preliminary spherical agglomerates of water soluble drug using natural polymer and cross-linking technique. J Control Release 40:179-186.
14. Hossain KS, Miyanaga K, Maeda H, Nemoto N. 2001. Sol-gel transition behavior of pure ι-carrageenan in both salt-free and added salt states. Biomacromolecules 2:442-449.
15. Prestwich GD, Marecak DM, Marecak JF, Vercruysse KP, Ziebell MR. 1998. Controlled chemical modification of hyaluronic acid. J Control Rel 53: 93-103.
16. Mangione MR, Giacomazza D, Bulone D, Martorana V, Cavallaro S, San Biagio PL. 2005. K(+) and Na(+) effects on the gelation properties of kappa-Carrageenan. Biophys Chem 113:129-135.
17. Naim S, Samuel B, Chauhan B, Paradkar A. 2004. Effect of potassium chloride and cationic drug on swelling, erosion and release from kappa-carrageenan matrices. AAPS Pharm Sci Tech 5:e25.
18. Asanza Teruel ML, Gontier E, Bienaime C, Nava Saucedo JE, Barbotin JN. 1997. Response surface analysis of chlortetracycline and tetracycline production with K-carrageenan immobilized Streptomyces aureofaciens. Enzyme Microb Technol 21: 314-320.
19. Box GEP, Hunter JS. 1957. Multi-factorial designs for exploring response surfaces. Ann Math Stat 28: 195-241.
20. Plackett RL, Burman JP. 1946. The design of optimum multifactorial experiments. Biometrika 33: 305-325.
21. Box GEP, Behnken DW. 1960. Some new three level desings for the study of quantitative variables. Technometrics 2:455-476.
22. Doehlert DH. 1970. Uniform shell designs. Appl Stat 19:231-239.
23. Vojnovic D, Chicoo D, Zenary HE. 1996. Doehlert experimental design applied to optimization and quality control of a granulation process in a high shear mixer. Int J Pharm 145:203-213.
24. Voinovich D, Moneghini M, Perissutti B, Filipovic-Grcic J, Grabnar I. 2000. Preparation in high-shear mixer of sustained-release pellets by melt pelletisation. Int J Pharm 203:235-244.
25. Geze A, Venier-Julienne MC, Mathieu D, Filmon R, Phan-Tan-Luu R, Benoit JP. 1999. Development of 5-iodo-2′-deoxyuridine milling process to reduce initial burst release from PLGA microparticles. Int J Pharm 178:257-268.
26. Gustavo Gonzalez A, Gonzalez-Arjona D. 1999. Computational program for evaluating and optimizing response-surface curves based on uniform shell designs. Talanta 49:433-439.
27. Hintze J. 2003. NCSS and PASS. 2003 ed., Kaysville, Utah: Number Cruncher Statistical Systems.
28. Derringer G, Suich R. 1980. Simultaneous optimization of several responses variables. J Qual Technol 2:214-219.
29. Bodeam X, Leucata SE. 1997. Optimization of hydrophilic matrix tablets using a D-optimal design. Int J Pharm 153:247-255.
30. Gohel MC, Patel MM, Amin AF. 2003. Development of modified release diltiazem HCl tablets using composite index to identify optimal formulation. Drug Dev Ind Pharm 29:565-574.
31. Shigeo O, Toshihiko K, Yousuke M, Horoshima S, Kozo T, Nagai T. 1994. A new attempt to solve the scale up problem for granulation using response surface methodology. J Pharm Sci 83:439-443.
32. Taylor MK, Ginsburg J, Hickey AJ, Gheyas F. 2000. Composite method to quantify powder flow as a screening method in early tablet or capsule formulation development. AAPS Pharm Sci Tech 1:(3). article 18.
33. Gibaldi M, Feldman S. 1967. Establishment of sink conditions in dissolution rate determinations-theoretical considerations and application to non-disintegrating dosage forms. J Pharm Sci 56:1238-1242.
34. Wagner JG. 1969. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci 58: 1253-1257.
35. Higuchi T. 1963. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145-1149.
36. Korsmeyer RW, Gurny R, Doelker EM, Buri P, Peppas NA. 1983. Mecanism of solute release from porous hydrophilic polymers. Int J Pharm 15:25-35.
37. Peppas NA. 1985. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 60:110-111.
38. Hixson AW, Crowell JH. 1931. Dependence of reaction velocity upon surface and agitation. Ind Eng Chem 23:923-931.
39. Pather SI, Russell I, Syce JA, Neau SH. 1998. Sustained release theophylline tablets by direct compression Part 1: Formulation and in vitro testing. Int J Pharm 164:1-10.
40. Kopcha M, Lordi N, Tojo KJ. 1991. Evaluation of release from selected thermosoftening vehicles. J Pharm Pharmacol 43:382-387.
41. An H, Seymour TA, Wu JW, Morrissey MT. 1994. Assay systems and characterization of Pacific whiting (Merluccius productus) protease. J Food Sci 59:277-281.
42. Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. 2005. Papain entrapment in alginate beads for stability improvement and site specific delivery: Physicochemical characterization and factorial optimization using neural network modeling. AAPS Pharm Sci Tech 6(2): E209-E222.
43. 3 factorial design and the desirability function. ARS Pharmaceutica 45:253-279.
44. Bodmeier R, Wang J. 1993. Microencapsulation of drugs with aqueous colloidal polymer dispersions. J Pharm Sci 82:191-194.
45. Bhardwaj SB, Shukia AJ, Collins CC. 1995. Effect of varying drug loading on particle size distribution and drug release kinetics of verapamil hydrochloride microspheres prepared with cellulose esters. J Microencapsul 12:71-81.
46. Bonferoni MC, Rossi S, Tamayo M, Pedraz JL, Dominguez Gil A, Caramella C. 1994. On the employment of λ carrageenan in a matrix system. II: λ carrageenan and hydroxypropyl-methylcellulose mixtures. J Control Release 30: 175-182.
47. Brazel CS, Peppas NA. 1999. Mechanisms of solute and drug transport in relaxing, swellable, hydrophilic glassy polymers. Polymers 40:3383-3398.
48. Hoffman AS. 2002. Hydrogels for biomedical applications. Adv Drug Del Rev 43:3-12.
49. Iborra JL, Manjon A, Canovas M. 1997. Immobilization in carrageenans. In: Bickerstaff GF, editor. Immobilization of enzymes and cells, 1st ed., Totowa, New Jersey: Humana Press, pp 53-60.
50. Severian D, Esteban C. 1998. Inclusion and release of proteins from polysaccharide-based polyion complexs. Adv Drug Deliv Rev 31:223-246.